Utah Medical Products, Inc. logo UTMD - Utah Medical Products, Inc.

Price: -- --
Annual Quarterly
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993
Revenue
Revenue 38.5 40.9 50.2 52.3 49.1 42.2 46.9 42.0 41.4 39.3 40.2 41.3 40.5 41.6 37.9 25.1 25.9 27.8 28.5 28.8 27.7 26.5 27.1 27.4 27.0 27.2 29.4 27.7 24.3 38.7 42 39.6 37
Cost of Revenue 18.6 16.8 20.2 20.1 18.1 16.6 17.4 15.7 15.0 15.6 16.0 16.3 16.2 16.2 15.5 11.9 12.1 12.8 12.7 12.6 11.9 11.4 11.2 11.6 11.6 12.1 11.5 11.4 10.2 18.1 20.8 20.7 19.5
Gross Profit 19.9 24.1 30.0 32.2 30.9 25.5 29.5 26.3 26.4 23.7 24.2 25.0 24.3 25.3 22.4 13.2 13.8 15.0 15.8 16.1 15.8 15.1 15.9 15.8 15.4 15.1 18.0 16.3 14.1 20.6 21.2 18.9 17.5
Operating Expenses
R&D Expenses 0.7 0.8 0.6 0.5 0.5 0.5 0.5 0.5 0.4 0.5 0.5 0.5 0.5 0.6 0.5 0.4 0.4 0.4 0.4 0.3 0.3 0.3 0.3 0.3 0.4 0.6 0.7 0.9 1 1.4 1.8 1.5 0
SG&A Expenses 7.8 5.6 12.7 11.9 11.5 11.4 11.4 7.2 6.9 7.0 8.0 8.3 9.0 9.5 10.0 3.9 4.0 4.3 4.7 5.0 6.2 4.7 4.9 4.9 5.8 6.2 6.8 6.6 6.1 5.9 6 6.1 7.6
Other Expenses 0 4.2 0 0 0 0 0 0 0.1 0 (0.0) 0 0.1 (0.0) 0 0 0 0 0 (0.0) 0.0 0 0 0 0 0 2.2 2.1 1.5 1.4 1.7 1.3 1
Operating Expenses 8.5 10.5 13.3 12.4 12.0 11.8 11.8 7.6 7.4 7.5 8.5 8.8 9.4 10.1 10.6 4.3 4.4 4.6 5.0 5.3 6.5 5.0 5.2 5.2 6.1 6.8 9.7 9.6 8.6 8.7 9.5 8.9 8.6
Operating Income
Operating Income 11.4 13.6 16.8 19.8 18.9 13.7 17.6 18.7 19.0 16.2 15.7 16.2 14.8 15.2 11.8 8.9 9.4 10.4 10.8 10.8 9.2 15.3 10.7 10.5 9.3 8.4 8.3 6.7 5.5 11.9 11.7 10 8.9
Interest Expense 0 0 0 0 0 0 0 0 0 0 0.1 0.3 0.4 0.7 0.9 0.0 0.1 0.2 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest Income 0 3.4 0 0.7 0.2 0.1 0.3 0 0 0 0 0 0 0 0 0 0.2 0.5 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Profitability
EBITDA 17.1 16.4 24.8 26.9 26.2 20.9 24.5 21.7 21.8 19.0 18.8 19.6 18.1 18.5 14.7 9.7 10.2 11.6 11.4 11.5 9.9 16.1 11.7 11.7 11.2 10.6 10.5 8.8 7.0 13.3 13.4 11.3 9.9
EBIT 14.1 13.6 18.4 19.8 18.9 13.7 17.6 18.7 19.0 16.2 15.7 16.3 14.9 15.2 11.9 9.1 9.6 11.0 10.8 10.8 9.2 15.3 10.7 10.5 9.3 8.4 8.3 6.7 5.5 11.9 11.7 10 8.9
Income Before Tax 14.1 16.8 20.1 20.7 19.1 13.8 17.9 19.5 19.1 16.4 15.5 15.8 14.5 14.5 11.1 9.0 9.6 10.8 12.0 12.4 10.2 10.9 11.2 11.0 9.5 8.4 8.5 7.6 6.8 13.7 12.9 10.9 10.6
Income Tax Expense 2.8 2.9 3.5 4.2 4.3 3.0 3.2 0.9 10.6 4.3 3.7 4.4 3.1 4.4 3.7 3.0 3.3 3.6 4.1 4.2 2.7 3.7 3.8 3.8 3.5 3.0 3.1 2.7 2.5 4.9 4.5 3.8 3.6
Net Income 11.3 13.9 16.6 16.5 14.8 10.8 14.7 18.6 8.5 12.1 11.8 11.4 11.4 10.2 7.4 6.0 6.3 7.2 7.9 8.2 7.5 10.2 20.8 7.2 5.9 5.4 5.5 4.9 4.3 8.8 8.4 7.1 7
Per Share Data
EPS (Basic) 3.41 3.96 4.57 4.53 4.05 2.95 3.96 4.97 2.29 3.22 3.14 3.02 3.02 2.74 2.04 1.66 1.73 1.87 2.01 2.07 1.91 2.32 4.59 1.46 1.18 0.90 0.76 0.59 0.51 0.94 0.83 0.68 0.60
EPS (Diluted) 3.48 3.96 4.57 4.52 4.04 2.94 3.94 4.95 2.28 3.22 3.14 3.01 3.02 2.74 2.03 1.65 1.72 1.86 1.98 2.02 1.80 2.19 4.25 1.36 1.14 0.90 0.76 0.59 0.51 0.93 0.82 0.68 0.60
Shares Outstanding 3.3 3.5 3.6 3.6 3.6 3.7 3.7 3.7 3.7 3.8 3.8 3.8 3.8 3.7 3.6 3.6 3.6 3.8 3.9 3.9 4.0 4.4 4.5 4.9 5.0 6.0 7.2 8.3 8.4 9.4 10.1 10.4 11.7
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2009 2008 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993
Current Assets
Cash & Cash Equivalents 85.8 83.0 92.9 75.1 61.0 51.6 42.8 51.1 39.9 26.4 0.4 0.1 1.8 0.8 0.3 0.4 0.4 0.6 1.4 1 3 5.1 1.6 0.8
Short-Term Investments 0 0 0 0 0 0 0 0 0.1 0 18.8 15.9 15.1 0.7 0 0 0 0 0 0 0 0 0 0
Net Receivables 3.5 4.1 3.4 5.5 5.1 4.1 4.7 4.0 3.6 3.2 3.2 3.5 3.7 3.3 3.1 3.6 4.0 4.1 4.5 4.7 5 6.7 6.4 6.1
Inventory 7.9 8.8 9.6 8.8 6.6 6.2 6.9 5.4 5.2 4.5 3.4 3.3 2.9 3.3 3.5 3.2 3.0 3.2 4 5.8 4.8 3.3 0.2 4.2
Other Current Assets 0.5 0.4 0.4 0 0.0 0 0 0.0 0 0 0.2 0.2 0.8 25.6 0.4 0.5 0.5 0.6 0.6 0.6 2.1 8.7 10.1 9.3
Total Current Assets 97.7 96.3 106.3 89.9 73.2 62.3 54.9 60.9 49.2 34.9 26.2 23.3 24.5 33.9 7.8 7.9 8.1 8.5 10.5 12.1 14.9 23.8 18.3 20.4
Non-Current Assets
Property, Plant & Equipment 9.9 9.8 10.6 10.2 10.6 11.3 10.7 10.4 11.6 10.0 8.1 8.1 9.1 9.0 8.9 8.9 9.8 11.0 12.5 13.3 13.4 8.9 8.1 7.5
Goodwill 14.1 13.6 13.7 13.4 14.1 14.2 14.0 13.7 14.1 13.5 7.2 7.2 7.2 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0.8 2.9 4.9 10.4 17.8 24.0 30.2 14.8 17.8 18.3 0.2 0.2 0.5 6.8 6.7 6.8 7.6 8.2 8.9 6.1 0.6 0.6 0.9 0.5
Long-Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 0 0 0 0 0 0 0 0 (3.1) (0.4) (0.2) (0.2) 7.7 0 0 0 0 0 0.1 0 0 0 0.1 (0.1)
Total Non-Current Assets 24.8 26.2 29.2 34.0 42.5 49.5 54.9 38.9 43.6 41.7 15.5 15.5 16.7 15.8 15.6 15.7 17.4 19.2 21.5 19.4 14 9.5 9.1 7.9
Total Assets 122.5 122.5 135.5 123.9 115.6 111.7 109.8 99.8 92.7 76.6 41.8 38.8 41.3 49.7 23.4 23.6 25.4 27.8 32 31.5 28.9 33.3 27.4 28.3
Current Liabilities
Account Payables 0.9 0.5 0.8 1.2 0.8 0.8 1.1 1.0 0.9 0.9 0.3 0.4 0.7 0.4 0.6 0.5 0.7 0.5 0.5 0.8 1.9 1.8 1.8 1.5
Short-Term Debt 0 0.1 0 0 0 0 0 0 0 0 0.3 0.3 0 0 0 0 0 0 0 0 0 0 0 0
Deferred Revenue 0 0 0 0 0 0 (0.0) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Liabilities 1.7 0.1 0.3 0.2 0.1 0.1 0.6 3.2 3.1 1.0 0.2 0.3 2.7 0 0 0 0 2.1 1.9 2 2.2 1.9 1.6 1.4
Total Current Liabilities 2.6 3.8 4.7 6.0 3.7 3.8 3.4 5.3 5.3 3.0 1.8 1.8 4.3 12.5 2.3 2.5 2.6 2.7 2.4 2.8 4.1 3.7 3.4 2.9
Non-Current Liabilities
Long-Term Debt 0 0 0 0 0 0 0 0 0 0 1.4 1.8 0 0 5.0 2.5 10 5.9 3.1 5.6 0 0 0 0
Deferred Tax Liabilities 0.5 1.1 1.4 2.1 2.7 2.8 2.8 3.1 3.6 4.3 0.6 0.4 0.8 0.7 0.4 0.4 0.4 0.4 0.4 0.5 0.3 0.2 0.3 0.3
Other Non-Current Liabilities 0 0 0.7 1.3 1.7 2.0 2.1 2.4 5.8 0 (0.0) 0.0 0 0 0 0 0 0 0.1 0 0.1 0.2 0.3 0.3
Total Non-Current Liabilities 0.7 1.4 2.4 3.7 4.8 5.1 5.2 5.5 9.3 4.3 2.0 2.2 0.8 0.7 5.3 2.9 10.4 6.3 3.6 6.1 0.4 0.4 0.6 0.6
Total Liabilities 3.3 5.1 7.1 9.6 8.5 8.9 8.7 10.8 14.6 7.3 3.8 4.0 5.1 13.2 7.7 5.4 13.1 9.0 6 8.9 4.5 4.1 4 3.5
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0 0 0 0 0 0
Retained Earnings 128.7 129.3 138.3 126.0 115.3 111.0 110.8 100.1 85.6 81.1 38.9 35.9 35.9 36.7 16.8 20.0 13.9 20.0 26.4 23.2 24 29.1 23.4 24.7
Accumulated Other Comprehensive Income (9.4) (11.9) (10.7) (12.0) (9.1) (8.3) (9.8) (11.3) (8.3) (12.2) (1.0) (1.1) 0.2 (0.3) (1.1) (1.8) (1.6) (1.2) (9.7) (8.2) (7) (6) (4.9) (3.7)
Total Stockholders' Equity 119.3 117.4 128.3 114.3 107.1 102.8 101.1 89.0 78.1 69.2 38.0 34.8 36.2 36.5 15.7 18.2 12.3 18.8 26 22.6 24.4 29.2 23.4 24.8
Total Liabilities & Equity 122.5 122.5 135.5 123.9 115.6 111.7 109.8 99.8 92.7 76.6 41.8 38.8 41.3 49.7 23.4 23.6 25.4 27.8 32 31.5 28.9 33.3 27.4 28.3
Debt Metrics
Total Debt 0.2 0.3 0.3 0.3 0.4 0.3 0.4 0 0 0 1.7 2.1 0 0 5.0 2.5 10 5.9 3.1 5.6 0 0 0 0
Net Debt (85.5) (82.7) (92.6) (74.7) (60.6) (51.3) (42.4) (51.1) (39.9) (26.4) (17.6) 2.0 (1.8) (0.8) 4.7 2.1 9.6 5.3 1.7 4.6 (3) (5.1) (1.6) (0.8)
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993
Operating Activities
Net Income 11.3 13.9 16.6 16.5 14.8 10.8 14.7 18.6 8.5 12.1 7.5 10.2 20.8 7.2 5.9 5.4 5.5 4.9 4.3 8.8 8.4 7.1 7
Depreciation & Amortization 0 2.8 6.4 7.1 7.3 7.2 6.9 3.0 2.8 2.8 0.7 0.8 1.0 1.2 1.9 2.2 2.2 2.1 1.5 1.4 1.7 1.3 1
Stock-Based Compensation 0.4 0.3 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.1 0 0 0 0 0 0 0 0 0 0 0 0 0
Change in Working Capital 0.3 (1.8) (0.2) (2.2) (1.0) 2.0 (4.3) (4.0) 6.1 (0.0) (2.5) 16.0 (14.4) (0.2) (0.1) 0.2 1.5 2.1 (0.7) 0.5 0.7 0.5 (1)
Other Non-Cash Items 2.7 (0.0) (0.0) 0.0 0.1 0.0 0.1 (0.4) 0.0 0.0 0.9 0.4 1.0 0.4 0.1 0.0 (0.0) 0.3 (0.3) 0.6 0.4 0 0.1
Operating Cash Flow 14.7 14.8 22.3 21.1 21.2 20.1 17.1 16.8 16.9 14.5 6.5 27.5 8.3 8.7 7.9 7.8 9.1 9.5 5 11.2 11.1 8.8 7.4
Investing Activities
Capital Expenditure (0.4) (0.2) (0.6) (0.8) (0.6) (0.9) (21.5) (0.4) (1.6) (3.3) (0.3) (0.4) (0.4) (0.5) (0.5) (0.4) (0.7) (4.7) (1.2) (5.9) (2.2) (2.3) (1.6)
Acquisitions 0 0 0 0 0 0 0 0 0 0 0 (1.0) 0 0 0 0 0 0 0 0 0 0 0
Purchases of Investments 0 0 0 0 0 0 0 0 0 0 (10.6) (22.1) (0.7) 0 0 0 0 0 (0.1) (3.3) (6.9) (3.5) (15)
Sales/Maturities of Investments 0 0 0 0 0 0 0 0.1 0 0 9.0 8.2 0.1 0 0 0 0 0 1.6 10 4.5 6.2 15.5
Other Investing Activities 0 0.0 0 (0.0) 0 0 (21) 0.9 0 (0.0) 0.0 0 0 0 0 (0.2) (0.0) (0.3) (7.8) 0 0.1 (0.1) 0.1
Investing Cash Flow (0.4) (0.2) (0.6) (0.8) (0.6) (0.9) (21.5) 0.5 (1.6) (3.3) (1.9) (15.3) (1.0) (0.5) (0.5) (0.6) (0.7) (5) (7.5) 0.8 (4.5) 0.3 (1)
Financing Activities
Net Debt Issuance 0 0 0 0 0 0 0 0 0 0 5.3 0 (5.0) 2.5 (7.5) 4.1 2.8 (2.5) 5.6 0 0 0 0
Stock Repurchased (8.4) (20.0) 0 (2.5) 0 (7.0) (0.4) (1.2) (2.9) (2.9) (9.4) (10.7) (2.8) (11.8) (0.2) (11.6) (12.1) (1.7) (5.4) (14.6) (4.2) (8.5) (7.2)
Dividends Paid (4.0) (4.3) (4.3) (3.2) (11.5) (4.1) (4.1) (4.0) (3.0) (3.9) (2.4) (1.3) 0 0 0 0 0 0 0 0 0 0 (0.7)
Other Financing Activities 0 0.4 0.1 0.2 0.6 0.4 0.3 0.5 0.3 0.4 0.0 0 0 0 0 0 0 0 0 0 0 0 0
Financing Cash Flow (12.3) (23.8) (4.2) (5.5) (10.9) (10.7) (4.2) (4.8) (2.7) (6.3) (5.7) (10.9) (6.9) (8.2) (7.4) (7.4) (9.1) (4.1) 0.4 (14) (3.1) (8.4) (7.3)
Cash Position
Net Change in Cash 2.8 (9.9) 17.8 14.1 9.4 8.8 (8.3) 11.2 13.6 3.0 (1.1) 1.1 0.5 (0.1) (0.0) (0.2) (0.7) (4.1) 0.4 (14) (3.1) (8.4) (7.3)
Cash at Beginning 83.0 92.9 75.1 61.0 51.6 42.8 51.1 39.9 26.3 23.3 1.8 0.8 0.3 0.4 0.4 0.6 1.4 1 3 5.1 1.6 0.8 1.6
Cash at End 85.8 83.0 92.9 75.1 61.0 51.6 42.8 51.1 39.9 26.3 0.7 1.8 0.8 0.3 0.4 0.4 0.6 (3.1) 3.4 (8.9) (1.5) (7.6) (5.7)
Free Cash Flow 14.3 14.6 21.6 20.3 20.7 19.3 (4.5) 16.4 15.3 11.2 6.1 27.0 7.9 8.1 7.3 7.5 8.4 4.8 3.8 5.3 8.9 6.5 5.8
Key Metrics 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993
Income Statement
Revenue 38.5 40.9 50.2 52.3 49.1 42.2 46.9 42.0 41.4 39.3 40.2 41.3 40.5 41.6 37.9 25.1 25.9 27.8 28.5 28.8 27.7 26.5 27.1 27.4 27.0 27.2 29.4 27.7 24.3 38.7 42 39.6 37
Gross Profit 19.9 24.1 30.0 32.2 30.9 25.5 29.5 26.3 26.4 23.7 24.2 25.0 24.3 25.3 22.4 13.2 13.8 15.0 15.8 16.1 15.8 15.1 15.9 15.8 15.4 15.1 18.0 16.3 14.1 20.6 21.2 18.9 17.5
Operating Income 11.4 13.6 16.8 19.8 18.9 13.7 17.6 18.7 19.0 16.2 15.7 16.2 14.8 15.2 11.8 8.9 9.4 10.4 10.8 10.8 9.2 15.3 10.7 10.5 9.3 8.4 8.3 6.7 5.5 11.9 11.7 10 8.9
Net Income 11.3 13.9 16.6 16.5 14.8 10.8 14.7 18.6 8.5 12.1 11.8 11.4 11.4 10.2 7.4 6.0 6.3 7.2 7.9 8.2 7.5 10.2 20.8 7.2 5.9 5.4 5.5 4.9 4.3 8.8 8.4 7.1 7
EPS (Diluted) 3.48 3.96 4.57 4.52 4.04 2.94 3.94 4.95 2.28 3.22 3.14 3.01 3.02 2.74 2.03 1.65 1.72 1.86 1.98 2.02 1.80 2.19 4.25 1.36 1.14 0.90 0.76 0.59 0.51 0.93 0.82 0.68 0.60
Balance Sheet
Cash & Equivalents 85.8 83.0 92.9 75.1 61.0 51.6 42.8 51.1 39.9 26.4 0.4 0.1 1.8 0.8 0.3 0.4 0.4 0.6 1.4 1 3 5.1 1.6 0.8
Total Assets 122.5 122.5 135.5 123.9 115.6 111.7 109.8 99.8 92.7 76.6 41.8 38.8 41.3 49.7 23.4 23.6 25.4 27.8 32 31.5 28.9 33.3 27.4 28.3
Total Debt 0.2 0.3 0.3 0.3 0.4 0.3 0.4 0 0 0 1.7 2.1 0 0 5.0 2.5 10 5.9 3.1 5.6 0 0 0 0
Stockholders' Equity 119.3 117.4 128.3 114.3 107.1 102.8 101.1 89.0 78.1 69.2 38.0 34.8 36.2 36.5 15.7 18.2 12.3 18.8 26 22.6 24.4 29.2 23.4 24.8
Cash Flow
Operating Cash Flow 14.7 14.8 22.3 21.1 21.2 20.1 17.1 16.8 16.9 14.5 6.5 27.5 8.3 8.7 7.9 7.8 9.1 9.5 5 11.2 11.1 8.8 7.4
Capital Expenditure (0.4) (0.2) (0.6) (0.8) (0.6) (0.9) (21.5) (0.4) (1.6) (3.3) (0.3) (0.4) (0.4) (0.5) (0.5) (0.4) (0.7) (4.7) (1.2) (5.9) (2.2) (2.3) (1.6)
Free Cash Flow 14.3 14.6 21.6 20.3 20.7 19.3 (4.5) 16.4 15.3 11.2 6.1 27.0 7.9 8.1 7.3 7.5 8.4 4.8 3.8 5.3 8.9 6.5 5.8